Daidzein suppresses TGF-β1-induced cardiac fibroblast activation via the TGF-β1/SMAD2/3 signaling pathway

被引:23
|
作者
Shu, Jiangcheng [1 ,2 ]
Hu, Lizhi [1 ]
Wu, Yichen [1 ,2 ]
Chen, Long [1 ]
Huang, Kai [1 ,2 ]
Wang, Zhaohui [1 ,2 ,3 ]
Liang, Minglu [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Clin Ctr Human Gene Res, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Clin Ctr Human Gene Res, 1277 Jiefang Ave, Wuhan 430022, Peoples R China
基金
中国国家自然科学基金;
关键词
Myocardial fibrosis; Daidzein; Cardiac fibroblasts; TGF-beta; 1; TGF-beta 1/SMAD2/3 signaling pathway; INFARCTION; FIBROSIS; SMAD3;
D O I
10.1016/j.ejphar.2022.174805
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Myocardial fibrosis is a concomitant bioprocess associated with many cardiovascular diseases (CVDs). Daidzein is an isoflavone that has been used for the treatment of CVDs. This study aimed to reveal its role in myocardial fibrosis. Our results indicate that daidzein had a nontoxic effect on cardiac fibroblasts and that TGF-beta 1 and TGF beta RI levels were gradually decreased by daidzein in a dose-dependent manner. In the current study, we show that daidzein significantly inhibited TGF-beta 1-induced mRNA and protein expression of alpha-SMA, collagen I, and collagen III. Accordingly, immunofluorescence staining of alpha-SMA was performed. Daidzein also inhibited TGF beta 1-induced cardiac fibroblast proliferation and migration. Mechanistically, daidzein inhibited the TGF-beta/SMAD signaling pathway induced by TGF-beta 1 in cardiac fibroblasts. Additionally, daidzein ameliorated MI-induced cardiac dysfunction and cardiac fibrosis in vivo. Based on these findings, we conclude that daidzein reduces TGF-beta 1-induced cardiac fibroblast activation by partially regulating the TGF-beta 1/SMAD2/3 signaling pathway.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma
    Jiang, Xiubo
    Zhang, Zhenhao
    Song, Changqin
    Deng, Hanzhi
    Yang, Runyu
    Zhou, Lvqi
    Sun, Yang
    Zhang, Qi
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2019, 307 : 158 - 166
  • [2] EFFECT OF EFONIDIPINE ON TGF-β1-INDUCED PROLIFERATION VIA SMAD2/3 DEPENDENT PATHWAY IN RAT CARDIAC FIBROBLASTS
    Lei, Bai
    Mori, Tatsuhiko
    Hitomi, Hirofumi
    Nakano, Daisuke
    Kimura, Shoji
    Nishiyama, Akira
    [J]. JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 314 - 314
  • [3] INHIBITION OF YAP BY VERTEPORFIN DECREASES TGF-β1 INDUCED RENAL FIBROBLAST ACTIVATION BY REGULATION OF TGF-β1/SMAD SIGNALING PATHWAY
    Park, Sung Kwang
    Jin, Jixiu
    Ku, Jeong Sang
    Park, Woong
    Lee, Sik
    Kim, Won
    Kang, Kyungpyo
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [4] Acute Hyperthermia Inhibits TGF-β1-induced Cardiac Fibroblast Activation via Suppression of Akt Signaling
    Masatoshi Narikawa
    Masanari Umemura
    Ryo Tanaka
    Takayuki Fujita
    Utako Yokoyama
    Tomoaki Ishigami
    Kazuo Kimura
    Kouichi Tamura
    Yoshihiro Ishikawa
    [J]. Scientific Reports, 8
  • [5] Acute Hyperthermia Inhibits TGF-β1-induced Cardiac Fibroblast Activation via Suppression of Akt Signaling
    Narikawa, Masatoshi
    Umemura, Masanari
    Tanaka, Ryo
    Fujita, Takayuki
    Yokoyama, Utako
    Ishigami, Tomoaki
    Kimura, Kazuo
    Tamura, Kouichi
    Ishikawa, Yoshihiro
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [6] Human amniotic epithelial cells attenuate TGF-β1-induced human dermal fibroblast transformation to myofibroblasts via TGF-β1/Smad3 pathway
    Zhao, Bin
    Liu, Jia-Qi
    Yang, Chen
    Zheng, Zhao
    Zhou, Qin
    Guan, Hao
    Su, Lin-Lin
    Hu, Da-Hai
    [J]. CYTOTHERAPY, 2016, 18 (08) : 1012 - 1024
  • [7] Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis
    Khalil, Hadi
    Kanisicak, Onur
    Prasad, Vikram
    Correll, Robert N.
    Fu, Xing
    Schips, Tobias
    Vagnozzi, Ronald J.
    Liu, Ruijie
    Thanh Huynh
    Lee, Se-Jin
    Karch, Jason
    Molkentin, Jeffery D.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (10): : 3770 - 3783
  • [8] RS4651 suppresses lung fibroblast activation via the TGF-β1/SMAD signalling pathway
    Li, Shirong
    Xu, Anjian
    Li, Yanmeng
    Tan, Chunting
    Regina, Giuseppe La
    Silvestri, Romano
    Wang, Haoyan
    Qi, Wenjie
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 903
  • [9] ALDH2 Activation Inhibited Cardiac Fibroblast-to-Myofibroblast Transformation Via the TGF-β1/Smad Signaling Pathway
    Yuan, Qiuhuan
    Cao, Shengchuan
    Dong, Qianqian
    Wang, Zheng
    Xu, Youshun
    Han, Qi
    Ma, Jingling
    Wei, Shujian
    Pang, Jiaojiao
    Yang, Feihong
    Zhang, Rui
    Liu, Baoshan
    Dai, Shuai
    Xue, Li
    Wang, Jiali
    Xue, Mengyang
    Xu, Tonghui
    Zheng, Wen
    Xu, Feng
    Chen, Yuguo
    Guo, Ping
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 73 (04) : 248 - 256
  • [10] CISD2 promotes lung squamous carcinoma cell migration and invasion via the TGF-β1-induced Smad2/3 signaling pathway
    Jingjing Zhang
    Lifang Pan
    Shirong Zhang
    Yuhong Yang
    Jiafeng Liang
    Shenglin Ma
    Qiong Wu
    [J]. Clinical and Translational Oncology, 2023, 25 : 3527 - 3540